Quantbot Technologies’s Guardant Health GH Stock Holding History

Quantbot Technologies’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-68,755	Closed	-$7.02M	–	1875
2025 Q4	$7.02M	Buy	+68,755	New	+$6.15M	0.23%	101
2025 Q1	–	Sell	-2,614	Closed	-$79.9K	–	1626
2024 Q4	$79.9K	Buy	+2,614	New	+$73.5K	﹤0.01%	1246
2023 Q3	–	Sell	-73,596	Closed	-$2.63M	–	1699
2023 Q2	$2.63M	Buy	+73,596	New	+$2.11M	0.17%	171
2021 Q3	–	Sell	-23,726	Closed	-$2.95M	–	1652
2021 Q2	$2.95M	Buy	23,726 +21,960	+1,243%	+$2.95M	0.23%	107
2021 Q1	$269K	Sell	1,766 -3,407	-66%	-$515K	0.03%	654
2020 Q4	$666K	Buy	+5,173	New	+$595K	0.07%	353
2020 Q2	–	Sell	-321	Closed	-$22K	–	1231
2020 Q1	$22K	Sell	321 -9,460	-97%	-$726K	0.01%	572
2019 Q4	$764K	Sell	9,781 -21,671	-69%	-$1.56M	0.08%	304
2019 Q3	$2.01M	Buy	31,452 +14,217	+82%	+$1.25M	0.2%	141
2019 Q2	$1.49M	Buy	+17,235	New	+$1.32M	0.15%	171

Other funds holding GH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Quantbot Technologies's GH Position: Q1 2026 in Review

Quantbot Technologies sold out of Guardant Health (GH) in Q1 2026, closing a stake of 68,755 shares — an estimated $7.02M sold.

Quantbot Technologies first reported a position in GH in Q2 2019 and held it in 10 quarters. The position peaked at $7.02M in Q4 2025. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

Quantbot Technologies reported no remaining Guardant Health position as of Q1 2026 after selling out during the quarter.
Quantbot Technologies sold 68,755 Guardant Health shares in Q1 2026, an estimated $7.02M.
Quantbot Technologies first reported a position in Guardant Health in Q2 2019 and held it in 10 quarters.
Quantbot Technologies's Guardant Health position peaked at $7.02M in Q4 2025.
481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Quantbot Technologies's 13F filing for Q1 2026, filed 13 May 2026.